PDS Biotech: Good data, but I’m a little worried about your finances

Pgiam/iStock via Getty Images

PDS Biotech (NASDAQ:PDSB) uses its Versammune platform in combination with tumor-specific proteins or antigens to develop targeted immunotherapies for oncology. I treated it in September 2021. It has a pre-clinical infectious disease program that we

PDSB pipeline

PDSB pipeline (PDSB website)

PDSB data

PDSB data (PDSB website)

Via the TPT service

Thank you for reading. At Total Pharma Tracker we offer:-

Our Android app and website offers a range of tools for do-it-yourself investors, including work-in-progress software where you can enter any ticker and get extensive curated research.

For investors who need hands-on assistance, our in-house experts walk through our tools and find the best investable stocks, complete with buy/sell strategies and alerts.

Sign up now for our free trial, request access to our tools and find out what we can do for you for free.